Abstract:Aims/Background Obesity and depression frequently co-occur, and the relationship between them is bidirectional. Being obese or overweight increases the risk of depression, and conversely, depression increases the risk of obesity or overweight. Emerging clinical research has shown that probiotics may be effective in treating obesity and associated depression. Modulating gut microbiota with probiotics may improve obesity-related depression, but current evidence is inconsistent. Methods We systematically searched PubMed, EMBASE, Web of Science, and Cochrane Library for randomized controlled trials examining probiotics for depression in obese adults. Mean difference (MD) in depression scores between probiotic and placebo groups was pooled across studies using random-effects models. Heterogeneity was assessed using I2 to explain heterogeneity in meta-regression analysis. To detect the publication bias of the included studies, a funnel plot, and Begg and Egger tests, were used. Possible heterogeneity moderators were detected by subgroup and sensitivity analyses, Galbraith plot, and graphic display of study heterogeneity (GOSH) analysis. Leave-one-out and Influence analyses were performed to assess sensitivity. Results Five trials (n = 488) were included. Overall, probiotics did not significantly improve depressive symptoms versus placebo (MD = 0.08, 95% confidence interval [CI] = -0.63 to 0.79, p = 0.82). Considerable heterogeneity among studies was observed (I2 = 63%). In subgroup analyses, probiotics significantly reduced depression as measured by the Edinburgh Postnatal Depression Scale (MD = -0.60, 95% CI = -1.17 to -0.03, p = 0.04) with no heterogeneity (I2 = 0%). Probiotics also decreased depressive symptoms after 12 weeks of supplementation (MD = -0.78, 95% CI = -1.58 to -0.01, p = 0.05) versus placebo. No publication bias was found using Begg and Egger tests. The GOSH diagnostics revealed three outliers, among the clusters identified by K-means, DBSCAN (Density-based spatial clustering of applications with noise algorithm), and GMM (Gaussian Mixture Model) analyses. Conclusion Overall, probiotics did not improve depressive symptoms in obesity. However, beneficial effects were observed with the Edinburgh Postnatal Depression Scale and short-term use of probiotic. Additional rigorous randomized controlled trials are warranted to elucidate the therapeutic potential of probiotics for obesity-related depression.

Obesity and Depression: Common Link and Possible Targets

Epigenetics in depression and gut-brain axis: A molecular crosstalk

Obesity and depression: Review on common neurobiological mechanisms and identification of potential drug targets.

Obesity and Depression. Some Neurochemical and Molecular Links

Characteristics of the Gut Microbiota in Bipolar Depressive Disorder Patients with Distinct Weight.

Microbiota Alters and Its Correlation with Molecular Regulation Underlying Depression in PCOS Patients

The potential biological mechanisms of obesity effects on depression: A systematic review of the literature and knowledge mining

Depression and obesity: evidence of shared biological mechanisms

Effects of obesity on depression: A role for inflammation and the gut microbiota

Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function

Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines

The interplay of gut microbiota, obesity, and depression: insights and interventions

Factors Associated with the Development of Depression and the Influence of Obesity on Depressive Disorders: A Narrative Review

Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review

Diet, Obesity, and Depression: A Systematic Review

Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes.

Adiposity in Depression or Depression in Adiposity? The Role of Immune-Inflammatory-Microbial Overlap

IDO Chronic Immune Activation and Tryptophan Metabolic Pathway: A Potential Pathophysiological Link Between Depression and Obesity

Ghrelin in Depression: A Promising Therapeutic Target

The Effect of Probiotics on Obesity with Comorbid Depression: A Systematic Review and Meta-Analysis

Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities